We focus on key areas in the healthcare industry and invest in companies that are positioned to scale.
1315 Capital provides expansion and growth capital to commercial-stage medical technology, healthcare service, and specialty pharmaceutical companies. The team believes that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses that positively impact patients, physicians, and the broader healthcare system.
The firm targets $10 to $25 million investments in commercial healthcare businesses that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.
In addition to experienced investing partners, 1315 Capital leverages an Operating Team model of CEO and longtime executive partner that work together to navigate diligence, drive decisions, and achieve premium exits.
Three operating teams contribute their collective experience to 1315 Capital in the areas of medical technologies, healthcare services, and specialty pharmaceuticals. These three teams have built companies from expansion and growth phases to businesses with revenues in excess of $100 million.